Zhishan Weixin Biotechnology
Chengdu
About Zhishan Weixin Biotechnology
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $296.7K
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2025)
Industries & Categories
Biotechnology, Health Care, Product Research
Canonical: https://fsome.com/organization/zhishan-weixin-biotechnology-127020 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.